@prefix dc: .
@prefix go: .
@prefix this: .
@prefix sub: .
@prefix beldoc: .
@prefix rdfs: .
@prefix rdf: .
@prefix xsd: .
@prefix dce: .
@prefix pav: .
@prefix np: .
@prefix belv: .
@prefix prov: .
@prefix chebi: .
@prefix hasAnnotation: .
@prefix species: .
@prefix occursIn: .
@prefix obo: .
@prefix pubmed: .
@prefix orcid: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
sub:_1 occursIn: obo:UBERON_0002107, species:9606;
hasAnnotation: sub:_2;
belv:translocationFrom go:0005622;
belv:translocationOf chebi:37054;
belv:translocationTo go:0005576 .
sub:_2 dc:subject "TextLocation";
rdf:value "Review" .
sub:assertion rdfs:label "sec(a(CHEBI:\"3-hydroxybutyrate\"))" .
}
sub:provenance {
beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
dce:title "BEL Framework Small Corpus Document";
dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
pav:authoredBy sub:_4;
pav:version "20131211" .
sub:_3 prov:value """During the fasting state, fatty acid oxidation (FAO) in the liver is incomplete; the
acetyl-CoA that is generated is not oxidized in the liver, but condenses into
ketone bodies (mainly acetoacetate and β-hydroxybutyrate) (Figure 1), which are
released into the plasma for subsequent oxidation in extrahepatic tissues.""";
prov:wasQuotedFrom pubmed:18705745 .
sub:_4 rdfs:comment "support@belframework.org";
rdfs:label "Selventa" .
sub:assertion prov:hadPrimarySource pubmed:18705745;
prov:wasDerivedFrom beldoc:, sub:_3 .
}
sub:pubinfo {
this: dc:created "2014-07-03T14:31:15.934+02:00"^^xsd:dateTime;
pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}